Dose-dependent pathogenicity and inflammatory imbalance in severely immunodeficient mice infected with mpox virusOA
The global spread of mpox continues to pose a threat to public health,with immuno-compromised patients being at greater risk for severe disease.This study aimed to establish a lethal severe infection model using NPG(NOD.Cg-Prkdc^(scid)Ⅱ2rg^(tm1)/Vst)mice,a strain with profound immunodeficiency,to simulate severe mpox in immu-nocompromised patients and investigate disease progression,viral replication kinet-ics,tissue tropism,and immune responses.In our study,mice were inoculated with three doses of mpox virus(high:2×10^(7),medium:2×10^(6),low:2×10^(5)TCID_(50)[50%tissue culture infective dose])or phosphate-buffered saline as a negative control.Body weight,clinical signs,and survival were monitored.Viral loads in plasma and tissues,histopathological changes,and inflammatory responses were evaluated to systematically characterize the pathogenicity of mpox virus in severely immunodefi-cient mice.The results showed that NPG mice were highly susceptible to mpox virus,showing a clear dose-dependent response.The high-dose group exhibited 100%lethality,and the medium-dose group had a 50%survival rate,whereas the low-dose and control groups survived throughout the study.Plasma and tissue viral loads,as well as histopathological severity,followed a dose-dependent pattern.Viremia remained persistently high,and animals that died at different time points exhibited uniformly high viral loads across multiple tissues.By day 10 postinfection,markedly elevated levels of pro-inflammatory cytokines were detected in plasma,whereas anti-inflammatory cytokines remained largely uninduced.We found that the infec-tion of severely immunodeficient mice with mpox virus results in dose-dependent lethality,persistent high viral loads,and a pronounced pro−/anti-inflammatory im-balance.These findings provide important insights into the pathogenesis of mpox in immunocompromised populations and develop a practical animal model for evaluat-ing therapeutic interventions.
Na Li;Ziqing Jia;Zhe Cong;Jianrong Ma;Jiahan Lu;Yongzhi Hou;Fei Wang;Jiasen Yang;Ting Chen;Jingjing Zhang;Dong Zhang;Jing Xue
NHC Key Laboratory of Human Disease Comparative Medicine,National Center of Technology Innovation for Animal Model,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing,ChinaNHC Key Laboratory of Human Disease Comparative Medicine,National Center of Technology Innovation for Animal Model,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing,ChinaNHC Key Laboratory of Human Disease Comparative Medicine,National Center of Technology Innovation for Animal Model,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing,ChinaNHC Key Laboratory of Human Disease Comparative Medicine,National Center of Technology Innovation for Animal Model,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing,ChinaNHC Key Laboratory of Human Disease Comparative Medicine,National Center of Technology Innovation for Animal Model,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing,ChinaNHC Key Laboratory of Human Disease Comparative Medicine,National Center of Technology Innovation for Animal Model,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing,ChinaNHC Key Laboratory of Human Disease Comparative Medicine,National Center of Technology Innovation for Animal Model,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing,ChinaNHC Key Laboratory of Human Disease Comparative Medicine,National Center of Technology Innovation for Animal Model,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing,ChinaNHC Key Laboratory of Human Disease Comparative Medicine,National Center of Technology Innovation for Animal Model,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing,ChinaNHC Key Laboratory of Human Disease Comparative Medicine,National Center of Technology Innovation for Animal Model,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing,ChinaNHC Key Laboratory of Human Disease Comparative Medicine,National Center of Technology Innovation for Animal Model,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing,ChinaNHC Key Laboratory of Human Disease Comparative Medicine,National Center of Technology Innovation for Animal Model,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing,China State Key Laboratory of Respiratory Health and Multimorbidity,Key Laboratory of Pathogen Infection Prevention and Control,Institute of Laboratory Animal Science,Ministry of Education,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing,China
医药卫生
inflammatory responselethal modelmpox virusNPG(NOD.Cg-Prkdc^(scid)Il2rg^(tm1)/Vst)miceviremia
《Animal Models and Experimental Medicine》 2026 (5)
P.1047-1055,9
National Key Research and Development Program of China,Grant/Award Number:2024YFC2309500Scientific Research Innovation Capability Support Project for Young Faculty,Grant/Award Number:SRICSPYF-ZY2025119Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences,China,Grant/Award Number:2025-I2M-XHJC-032 and 2025-I2M-KJ-021Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project,Grant/Award Number:2025ZD01904300。
评论